NO814095L - Fremgangsmaate ved fremstilling av et aminopenicellinderivat - Google Patents
Fremgangsmaate ved fremstilling av et aminopenicellinderivatInfo
- Publication number
- NO814095L NO814095L NO814095A NO814095A NO814095L NO 814095 L NO814095 L NO 814095L NO 814095 A NO814095 A NO 814095A NO 814095 A NO814095 A NO 814095A NO 814095 L NO814095 L NO 814095L
- Authority
- NO
- Norway
- Prior art keywords
- polymers
- approx
- molecular weight
- polymer
- fibers
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 10
- 238000002360 preparation method Methods 0.000 title description 2
- 238000006243 chemical reaction Methods 0.000 claims description 9
- HYBBIBNJHNGZAN-UHFFFAOYSA-N furfural Chemical compound O=CC1=CC=CO1 HYBBIBNJHNGZAN-UHFFFAOYSA-N 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 239000000203 mixture Substances 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Chemical group 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 229910052700 potassium Chemical group 0.000 claims description 2
- 239000011591 potassium Chemical group 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims 4
- 239000000835 fiber Substances 0.000 claims 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 claims 2
- 150000001336 alkenes Chemical class 0.000 claims 2
- 239000003054 catalyst Substances 0.000 claims 2
- WOZVHXUHUFLZGK-UHFFFAOYSA-N dimethyl terephthalate Chemical compound COC(=O)C1=CC=C(C(=O)OC)C=C1 WOZVHXUHUFLZGK-UHFFFAOYSA-N 0.000 claims 2
- 238000001125 extrusion Methods 0.000 claims 2
- 235000011187 glycerol Nutrition 0.000 claims 2
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 claims 2
- 239000011654 magnesium acetate Substances 0.000 claims 2
- 229940069446 magnesium acetate Drugs 0.000 claims 2
- 235000011285 magnesium acetate Nutrition 0.000 claims 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims 2
- 238000006068 polycondensation reaction Methods 0.000 claims 2
- 238000006116 polymerization reaction Methods 0.000 claims 2
- 239000004246 zinc acetate Substances 0.000 claims 2
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical compound FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims 1
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 claims 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims 1
- 150000001242 acetic acid derivatives Chemical class 0.000 claims 1
- 150000004703 alkoxides Chemical class 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 229910000410 antimony oxide Inorganic materials 0.000 claims 1
- 238000000149 argon plasma sintering Methods 0.000 claims 1
- FPCJKVGGYOAWIZ-UHFFFAOYSA-N butan-1-ol;titanium Chemical compound [Ti].CCCCO.CCCCO.CCCCO.CCCCO FPCJKVGGYOAWIZ-UHFFFAOYSA-N 0.000 claims 1
- JVLRYPRBKSMEBF-UHFFFAOYSA-K diacetyloxystibanyl acetate Chemical compound [Sb+3].CC([O-])=O.CC([O-])=O.CC([O-])=O JVLRYPRBKSMEBF-UHFFFAOYSA-K 0.000 claims 1
- 150000002009 diols Chemical class 0.000 claims 1
- 230000032050 esterification Effects 0.000 claims 1
- 238000005886 esterification reaction Methods 0.000 claims 1
- YAMHXTCMCPHKLN-UHFFFAOYSA-N imidazolidin-2-one Chemical group O=C1NCCN1 YAMHXTCMCPHKLN-UHFFFAOYSA-N 0.000 claims 1
- 238000002513 implantation Methods 0.000 claims 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims 1
- 229910052753 mercury Inorganic materials 0.000 claims 1
- 229910052751 metal Inorganic materials 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 150000002739 metals Chemical class 0.000 claims 1
- 239000000178 monomer Substances 0.000 claims 1
- 210000003205 muscle Anatomy 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- VTRUBDSFZJNXHI-UHFFFAOYSA-N oxoantimony Chemical compound [Sb]=O VTRUBDSFZJNXHI-UHFFFAOYSA-N 0.000 claims 1
- 150000002989 phenols Chemical class 0.000 claims 1
- TVRGPOFMYCMNRB-UHFFFAOYSA-N quinizarine green ss Chemical compound C1=CC(C)=CC=C1NC(C=1C(=O)C2=CC=CC=C2C(=O)C=11)=CC=C1NC1=CC=C(C)C=C1 TVRGPOFMYCMNRB-UHFFFAOYSA-N 0.000 claims 1
- 230000005855 radiation Effects 0.000 claims 1
- 239000011347 resin Substances 0.000 claims 1
- 229920005989 resin Polymers 0.000 claims 1
- 150000003336 secondary aromatic amines Chemical class 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- RINCXYDBBGOEEQ-UHFFFAOYSA-N succinic anhydride Chemical class O=C1CCC(=O)O1 RINCXYDBBGOEEQ-UHFFFAOYSA-N 0.000 claims 1
- 229940014800 succinic anhydride Drugs 0.000 claims 1
- 238000005809 transesterification reaction Methods 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 description 19
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 17
- 229960003022 amoxicillin Drugs 0.000 description 16
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 16
- 229930182555 Penicillin Natural products 0.000 description 8
- 230000003115 biocidal effect Effects 0.000 description 8
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 6
- 229960000723 ampicillin Drugs 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 229940088710 antibiotic agent Drugs 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 150000002960 penicillins Chemical class 0.000 description 5
- 241000700159 Rattus Species 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241000191938 Micrococcus luteus Species 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000000721 bacterilogical effect Effects 0.000 description 3
- 238000011835 investigation Methods 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 238000002828 disc diffusion antibiotic sensitivity testing Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 201000004813 Bronchopneumonia Diseases 0.000 description 1
- 208000032376 Lung infection Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010037597 Pyelonephritis acute Diseases 0.000 description 1
- 206010037601 Pyelonephritis chronic Diseases 0.000 description 1
- 241000700157 Rattus norvegicus Species 0.000 description 1
- 201000001555 acute pyelonephritis Diseases 0.000 description 1
- 206010051223 adenoiditis Diseases 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 201000006368 chronic pyelonephritis Diseases 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- MYTMXVHNEWBFAL-UHFFFAOYSA-L dipotassium;carbonate;hydrate Chemical compound O.[K+].[K+].[O-]C([O-])=O MYTMXVHNEWBFAL-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 230000002489 hematologic effect Effects 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000013048 microbiological method Methods 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 208000008423 pleurisy Diseases 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 201000007094 prostatitis Diseases 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 201000009890 sinusitis Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Substances [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000001635 urinary tract Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT26351/80A IT1134541B (it) | 1980-12-02 | 1980-12-02 | Derivato della ammino-penicillina,processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO814095L true NO814095L (no) | 1982-06-03 |
Family
ID=11219290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO814095A NO814095L (no) | 1980-12-02 | 1981-12-01 | Fremgangsmaate ved fremstilling av et aminopenicellinderivat |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4327105A (el) |
| EP (1) | EP0053308A1 (el) |
| JP (1) | JPS57120592A (el) |
| DE (1) | DE3111035A1 (el) |
| DK (1) | DK532381A (el) |
| FI (1) | FI813776L (el) |
| GB (1) | GB2088358A (el) |
| GR (1) | GR77299B (el) |
| IT (1) | IT1134541B (el) |
| NO (1) | NO814095L (el) |
| PT (1) | PT74009B (el) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4540689A (en) * | 1981-09-22 | 1985-09-10 | Kureha Kagaku Kogyo Kabushiki Kaisha | Penicillin derivative |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| YU32491B (en) * | 1968-08-08 | 1974-12-31 | Pliva Pharm & Chem Works | Postupak za dobivanje novih penicilina |
| US3647781A (en) * | 1969-08-14 | 1972-03-07 | Squibb & Sons Inc | Imines of nitroheterocyclic aldehydes and compounds of the penicllanic acid or cepham series |
| US3959258A (en) * | 1970-05-25 | 1976-05-25 | Bayer Aktiengesellschaft | Ureidoacetamido-penicillins |
| US3669958A (en) * | 1970-06-29 | 1972-06-13 | Bristol Myers Co | 6-{8 n-(substituted-imidoyl)-aminoacetamido{9 pencillanic acids |
| US3886140A (en) * | 1972-05-30 | 1975-05-27 | Squibb & Sons Inc | Penicillin derivatives |
| FR2210383A1 (en) * | 1972-12-20 | 1974-07-12 | Aries Robert | Alpha aldimino-penicillins prepn. - from an amino penicillin and 5-nitro furfural or 5-nitro thien aldehyde |
-
1980
- 1980-12-02 IT IT26351/80A patent/IT1134541B/it active
-
1981
- 1981-03-09 US US06/241,641 patent/US4327105A/en not_active Expired - Fee Related
- 1981-03-10 GB GB8107508A patent/GB2088358A/en not_active Withdrawn
- 1981-03-20 DE DE19813111035 patent/DE3111035A1/de not_active Withdrawn
- 1981-11-13 EP EP81109665A patent/EP0053308A1/en not_active Withdrawn
- 1981-11-18 PT PT74009A patent/PT74009B/pt unknown
- 1981-11-25 FI FI813776A patent/FI813776L/fi not_active Application Discontinuation
- 1981-11-30 GR GR66650A patent/GR77299B/el unknown
- 1981-12-01 JP JP56191904A patent/JPS57120592A/ja active Pending
- 1981-12-01 DK DK532381A patent/DK532381A/da not_active Application Discontinuation
- 1981-12-01 NO NO814095A patent/NO814095L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI813776L (fi) | 1982-06-03 |
| JPS57120592A (en) | 1982-07-27 |
| GR77299B (el) | 1984-09-11 |
| US4327105A (en) | 1982-04-27 |
| PT74009A (en) | 1981-12-01 |
| DE3111035A1 (de) | 1982-07-01 |
| EP0053308A1 (en) | 1982-06-09 |
| IT8026351A0 (it) | 1980-12-02 |
| GB2088358A (en) | 1982-06-09 |
| DK532381A (da) | 1982-06-03 |
| PT74009B (en) | 1983-04-26 |
| IT1134541B (it) | 1986-08-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101234538B1 (ko) | 생분해성 선형 랜덤 코폴리에스테르 및 그의 제조방법과사용방법 | |
| US7999051B2 (en) | Furanone copolymers | |
| US9480780B2 (en) | Compositions and devices of poly-4-hydroxybutyrate | |
| US9290612B2 (en) | Compositions and devices of poly-4-hydroxybutyrate | |
| US4916209A (en) | Bioabsorbable polydepsipeptide, preparation and use thereof | |
| US20090138041A1 (en) | Halogenated Cyclic Lactones and Polymers Made Therefrom | |
| US4994551A (en) | Bioabsorbable co-polydepsipeptide | |
| US8071691B2 (en) | Furanone endcapped polymers | |
| NO814095L (no) | Fremgangsmaate ved fremstilling av et aminopenicellinderivat | |
| CN100540585C (zh) | 含磷脂酰胆碱基团的可生物降解聚酯及其制备方法 | |
| CN111423569B (zh) | 一种抑菌可降解聚对苯二甲酸乙二醇酯共聚酯及其制备方法 | |
| US4044130A (en) | Compositions for the control of microorganisms | |
| CN101003539A (zh) | 西林类化合物的氨丁三醇盐及其制备方法 | |
| US20090069504A1 (en) | Furanone-Initiated Polymers | |
| US20210084897A1 (en) | Bio-based material with antibacterial effect and use thereof | |
| NZ208119A (en) | Silver pseudomonate and pharmaceutical compositions | |
| WO2019088917A1 (en) | Imidazolium-quaternary ammonium copolymers as novel antibacterial and antifungal materials | |
| CN112168980B (zh) | 一种基因激活型抗菌生物活性骨修复材料及其制备方法和应用 | |
| US3821382A (en) | 5-nitrofuryl derivatives as antibacterial agents | |
| CN110669223A (zh) | 一种葡聚糖接枝树枝状聚酰胺-胺聚合物及其制备方法和应用 | |
| CN115089733B (zh) | 用于治疗高赖氨酸血症的组合物及应用 | |
| US3562286A (en) | Nitrofuryl isoxazole derivatives | |
| US2703328A (en) | Rearrangement products of mycomycin | |
| TWI342313B (en) | Vinyl alcohol-vinyl hydroxyl benzoate copolymer and composite film comprising the same | |
| US3574209A (en) | Quaternary ammonium salts of methenamine |